Stoke Therapeutics, Inc. reports

Company 1 identity field
Location
Bedford, MA
SEC filing record 1 source field
Fiscal year end
31 December
Stoke Therapeutics, Inc. has filed 589 SEC EDGAR filings since 24 Nov 2014

SEC filing history

Showing 326-350 of 589 matching filings.

Per page
25
Current page
14
144 File 001-38938

144 filing

Filing date
03 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38938

ARS

Filing date
27 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38938

DEFA14A

Filing date
27 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38938

DEF 14A

Filing date
27 Apr 2023
Reporting date
13 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38938

PRE 14A

Filing date
17 Apr 2023
Reporting date
13 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-271237

S-8

Filing date
13 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-270744

S-8

Filing date
22 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91051

STOKE THERAPEUTICS, INC.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91051

MS INITIAL

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91051

SC 13G/A filing

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91051

SCHEDULE 13G/A

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Feb 2023
Reporting date
03 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91051

SC 13G/A

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Feb 2023
Reporting date
31 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91051

COWEN FINANCIAL PRODUCTS LLC

Filing date
25 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .